AC Immune SA (ACIU) Financials

ACIU Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 217.4 million 26.4 million
2023-09-30 156.2 million 18.9 million
2023-06-30 173.8 million 18.8 million
2023-03-31 185.1 million 17.7 million

ACIU Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -19.5 million 947799
2023-09-30 -14.8 million 946968
2023-06-30 -15.9 million 1.4 million
2023-03-31 -18.6 million 1.6 million

ACIU Net Income

No data available :(

ACIU Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 122.5 million - 4.2 million
2023-09-30 87.3 million - 2.6 million
2023-06-30 103.5 million - 2.8 million
2023-03-31 115.4 million - 2.9 million

ACIU Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 103.2 million
2023-09-30 92.5 million
2023-06-30 94.1 million
2023-03-31 91.5 million

ACIU Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 197408 17.4 million 803905 -
2023-09-30 305826 13.6 million 3.8 million -
2023-06-30 172414 15.2 million 4.1 million -
2023-03-31 218815 15.2 million 4.5 million -

ACIU Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 17.6 million 17.4 million
2023-09-30 - 13.6 million
2023-06-30 - 15.2 million
2023-03-31 - 15.2 million

ACIU

Price: $2.39

52 week price:
1.78
5.14

Earnings Per Share: -0.71 USD

P/E Ratio: -3.24

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 182100

Ebitda: -8.8 million

Market Capitalization: 232.4 million

Links: